The many faces of atrophy in gynecologic cytology

Clinics in Laboratory Medicine

Volumn 23, Issue 3, 2003, Pages 659-679

  Tambouret, Rosemary H ^a,b   Wilbur, David C ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; MEDROXYPROGESTERONE; PROGESTERONE; TAMOXIFEN;

CANCER SCREENING; CELL STRUCTURE; CYTOLOGY; GYNECOLOGY; HUMAN; POSTMENOPAUSE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; REVIEW; UTERINE CERVIX CANCER; VAGINA ATROPHY;

EID: 0141619391     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-2712(03)00059-3     Document Type: Review

References (85)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-33.
2. Batrinos M, Eustratiades M. The diagnostic significance of parabasal cells. I. Correlation with the clinical diagnosis in 209 patients. Acta Cytol 1975;19:97-9.
3. Wied GL, Bibbo M, Keebler CM. Evaluation of the endocrinologic condition of the female genital tract by exfoliative cytology. In: Wied GL, Bibbo M, Keebler CM, Koss LG, Patten SF, Rosenthal DL, editors. Compendium on diagnostic cytology, 8th edition. Chicago: Tutorials of cytology; 1997. p. 55-64.
4. Von Haam E. The cytology of pregnancy. Acta Cytol 1961;5:320-9.
5. Pisharodi LR, Jovanoska S. Spectrum of cytologic changes in pregnancy. A review of 100 abnormal cervicovaginal smears, with emphasis on diagnostic pitfalls. Acta Cytol 1995;39:905-8.
6. Schneider V. Cytology in pregnancy. In: Wied GL, Bibbo M, Keebler CM, Koss LG, Patten SF, Rosenthal DL, editors. Compendium on diagnostic cytology, 8th edition. Chicago: Tutorials of cytology; 1997. p. 50-4.
7. Danos M, Holmquist ND. Cytologic evaluation of decidual cells. a report of two cases with false abnormal cytology. Acta Cytol 1967;11:325-50.
8. Murad TM, Terhart K, Flint A. Atypical cells in pregnancy and postpartum smears. Acta Cytol 1981;25:623-30.
9. Rhatigan RM. Endocervical gland atypia secondary to Aria-Stella change. Arch Pathol Lab Med 1992;116:943-6.
10. Mulvany NJ, Khan A, Ostor A. Arias-Stella reaction associated with cervical pregnancy: report of a case with a cytologic presentation. Acta Cytol 1994;18:218-22.
11. Benoit JL, Kini SR. Arias-Stella reaction-like changes in endocervical glandular epithelium in cervical smears during pregnancy and postpartum states-a potential diagnostic pitfall. Diagn Cytopathol 1996;14:349-55.
12. Naib ZM. Single trophoblastic cells as a source of error in the interpretation of routine vaginal smears. Cancer 1961;14:1183-4.
13. Fiorella RM, Cheng J, Kragel PJ. Papanicolaou smears in pregnancy: positivity of exfoliated cells for human chorionic gonadotropin and human placental lactogen. Acta Cytol 1992;37:451-6.
14. Michael CW, Esfahani FM. Pregnancy-related changes: a retrospective review of 278 cervical smears. Diagn Cytopathol 1996;17:99-107.
15. McLennan MT, McLennan CE. Hormonal patterns in vaginal smears from puerperal women. Acta Cytol 1975;19:431-3.
16. Holmquist N. The cytology of early abortion. Acta Cytol 1967;11:262-6.
17. Frank TS, Bath N, Noumoff JS, Yeh IT. Residual trophoblastic tissue as a source of highly atypical cells in the postpartum cervicovaginal smear. Acta Cytol 1990;35:105-8.
18. Kobayashi TK, Yuasa M, Fujimoto T, Fukuda M, Harami K, Hayashi K. Cytologic findings in postpartum and postabortal smears. Acta Cytol 1980;24:328-34.
19. Danos ML. Post partum cytology: observations over a four year period. Acta Cytol 1968;12:309-12.
20. Soloway HB. Vaginal and cervical cytology of the early puerperium. Acta Cytol 1969;13:310-3.
21. Schwallie PC, Assenzo JR. Contraceptive use-efficacy study utilizing medroxyprogesterone acetate administered as an intramuscular injection once every 90 days. Fertil Steril 1973;24:331-9.
22. Bonte J, Decoster JM, Ide P. The vaginal cytologic evaluation as a practical link between hormone blood levels and tumor hormone dependency in exclusive medroxyprogesterone treatment of recurrent or metastatic endometrial adenocarcinoma. Acta Cytol 1977;21:218-24.
23. Valente PT, Schantz HD, Trabal JF. Cytologic changes in cervical smears associated with prolonged use of depot-medroxyprogesterone. Cancer 1998;84:328-34.
24. Bahamondes L, Trevisan M, Andrade L, Marchi NM, Castro S, Diaz J, et al. The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera. Contraception 2000;62:23-7.
25. Volk EE, Jax JM, Kuntzman TJ. Cytologic findings in cervical smears in patients using intramuscular medroxyprogesterone acetate (Depo-provera) for contraception. Diagn Cytopathol 2000;23:161-4.
26. Kaptain S, Bloom LI, Weir MM. Hormonal effects of Depo-Provera in cervical smears: a comparison with Triphasil and postmenopausal effects. Cancer 2002;96:74-82.
27. Koss LG. Koss's diagnostic cytology and its histopathologic basis, 4th edition. Philadelphia: JB Lippincott Co.; 1992.
28. Van Peenen HJ, Bickerstaff LK. Clinical insignificance of "dirty" background in cervicovaginal smears [letter]. Acta Cytol 1983;27:380.
29. Naylor B, Ziabkowski TA. Cyanophilic bodies in cervico-vaginal smears. Acta Cytol 1976;20:340-2.
30. Abdulla M, Hombal S, Kanbour A, Becich M, Stankovich D, Ries A, et al. Characterizing "blue blobs": immunohistochemical staining and ultrastructural study. Acta Cytol 2000;44:547-50.
31. Weir MM, Bell DA. Transitional cell metaplasia of the cervix: a newly described entity in cervicovaginal smears. Diagn Cytopathol 1998;18:222-6.
32. Reyes FI, Winter JS, Faiman C. Pituitary ovarian relationships preceding the menopause: a cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prlactin, estradiol and progesterone levels. Am J Obstet Gynecol 1977;129:557-64.
33. Lee SJ, Lenton EA, Sexton L. The effect of age on the cyclical patterns of LH, FSH, estradiol and progesterone in women with regular menstrual cycles. Hum Reprod 1988;3:851-5.
34. Fitzgerald CT, Self MW, Killick SR. Age-related changes in the female reproductive cycle. Br J Obstet Gynaecol 1994;101:229-33.
35. Santoro N, Banwell T, Tortoriello D, Lieman H, Adel T, Skurnick J. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. Am J Obstet Gynecol 1998;178:732-41.
36. Eustratiades M, Batrinos M. The diagnostic significance of parabasal cells. II. Rate of their disappearance and reappearance under estrogen administration and withdrawal. Cyanophilic bodies in cervico-vaginal smears. Acta Cytol 1975;19:100-2.
37. Sheils LA, Wilbur DC. Atypical squamous cells of undetermined significance. Stratification of the risk of association with, or progression to, squamous intraepithelial lesions based on morphologic subcategorization [see comments]. Acta Cytol 1997;41:1065-72.
38. Caruso S, Roccasalva L, Sapienza G, Zappala M, Nuciforo F, Biondi S. Laryngeal cytological aspects in women with surgically induced menopause who were treated with transdermal estrogen replacement therapy. Fertil Steril 2000;74:1073-9.
39. Chretien MF, Lebouvier B, Denis A, Chappard D. Cytomorphometric analysis of vaginal cells during normal cycle, under oral contraceptive therapy or in-vitro fertilization stimulation protocol. Hum Reprod 1998;13:2767-71.
40. Heber KR. The effect of progestogens of vaginal cytology. Acta Cytol 1975;19:103-9.
41. Ferrazzi E, Cartei G, Mattarazzo R, Fiorentino M. Oestrogen-like effect of tamoxifen on vaginal epithelium. BMJ 1977;60:1351-2.
42. Boccardo F, Bruzzi P, Rubagotti A, Nicolo G, Rosso R. Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology 1981;38:281-5.
43. Opjorden SL, Caudill JL, Humphrey SK, Salomao DR. Small cells in cervical-vaginal smears of patients treated with tamoxifen. Cancer 2001;93:23-8.
44. Yang YJ, Trapkin LK, Demoski RK, Bellerdine J, Powers CN. The small blue cell dilemma associated with tamoxifen therapy. Arch Pathol Lab Med 2001;125:1047-50.
45. van der Laak JA, de Bie LM, de Leeuw H, de Wilde PC, Hanselaar AG. The effect of Replens on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry. J Clin Pathol 2002;55:446-51.
46. Van Niekerk WA. Cervical cytological abnormalities caused by folic acid deficiency. Acta Cytol 1966;10:67-73.
47. Piyathilake CJ, Macaluso M, Johanning GL, Whiteside DC, Heimburger DC, Giuliano A. Methylenetetrahydrafolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res 2000;20:1751-7.
48. Goodman MT, McDuffie K, Hernandez B, Wilkens LR, Bertram CC, Killeen J, et al. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers & Prev 2001;10:1275-80.
49. Lambropoulos AF, Agorastos T, Foka ZJ, Chrisafi S, Constantinidis TC, Bontis J, et al. Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia. Cancer Lett 2003;191:187-91.
50. Burton JL, Wells M. The effect of phytoestrogens on the female genital tract. J Clin Pathol 2002;55:401-7.
51. Kim Sh SH, Kaminker P, Campisi J. Telomeres, aging and cancer: in search of a happy ending. Oncogene 2002;21:503-11.
52. Kurman RJ, Solomon D. The Bethesda system for reporting cervical/vaginal cytologic diagnoses. New York: Springer-Verlag; 1994. p. 1-81.
53. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The Bethesda System 2001: terminology for reporting the results of cervical cytology. JAMA 2002;287:2114-9.
54. DeMay RM. The art and science of cytopathology. Chicago: American Society of Clinical Pathology Press; 1995.
55. Abati A, Jaffurs W, Wilder AM. Squamous atypia in the atrophic cervical vaginal smear: a new look at an old problem. Cancer 1998;84:218-25.
56. DeMay RM. Hyperchromatic crowded groups: pitfalls in pap smear diagnosis. Am J Clin Pathol 2000;114(Suppl 1):S36-43.
57. Koss LG. Transitional cell metaplasia of cervix: a misnomer. Am J Surg Pathol 1997;22:774-5.
58. Ng W-K, Cheung LKN, Li ASM, Cheung FMF, Chow JCY. Transitional cell metaplasia of the uterine cervix is related to human papilloma virus. Cancer Cytopathol 2002;96:250-8.
59. Saminathan T, Lahoti C, Kannan V, Kline TS. Postmenopausal squamous-cell atypias: a diagnostic challenge. Diagn Cytopathol 1994;11:226-30.
60. Rader AE, Rose PG, Rodriguez M, Mansbacher S, Pitlik D, Abdul-Karim FW. Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management. Acta Cytol 1999;43:357-62.
61. Keating JT, Wang HH. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women. Cancer 2001;93:100-5.
62. Quddus MR, Sung CJ, Steinhoff MM, Lauchlan SC, Singer DB, Hutchinson ML. Atypical squamous metaplastic cells: reproducibility, outcome, and diagnostic features on ThinPrep Pap test. Cancer 2001;93:16-22.
63. Siegler EE. Cervical carcinoma in the aged. Am J Obstet Gynecol 1969;103:1093-7.
64. Duffy BJ, Lipworth L, Tuthill R. Papnicolaou testing - are we screening the wrong women? [letter]. N Engl J Med 1976;294:223.
65. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
66. Weintraub NT, Violi E, Freedman ML. Cervical cancer screening in women aged 65 and over. J Am Geriatr Soc 1987;35:870-5.
67. Kaminski PF, Sorosky JI, Wheelock JB, Stevens CW Jr. The significance of atypical cervical cytology in an older population. Obstet Gynecol 1989;73:13-5.
68. Symmans F, Mechanic L, MacConnell P, DaSilva K, Stricker B, Nuovo GJ. Correlation of cervical cytology and human papillomavirus DNA detection in postmenopausal women. Int J Gynecol Pathol 1992;11:204-9.
69. Jovanovic AS, McLachlin CM, Shen L, Welch WR, Crum CP. Postmenopausal squamous atypia: a spectrum including "pseudo-koilocytosis" [see comments]. Mod Pathol 1995;8:408-12.
70. Nuovo GJ, Cottral S, Richart RM. Occult human papillomavirus infection of the uterine cervix in postmenopausal women. Am J Obstet Gynecol 1989;160:340-4.
71. Ferenczy A, Gelfand MM, Franco E, Mansour N. Human papillomavirus infection in postmenopausal women with and without hormone therapy. Obstet Gynecol 1997;90:7-11.
72. Schiffman M, Adrianza ME. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol 2000;44:726-42.
73. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9.
74. Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study (ALTS). J Natl Cancer Inst 2002;94:102-7.
75. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-90.
76. Sellors J, Karwalajtys T, Kaczorowski J, Mahony J, Lytwyn A, Chong S, et al. Prevalence of infection with carcinogenic human papillomavirus among older women. CMAJ 2002;167:871-3.
77. Pambuccian S, Lundeen S, Woronzoff K, Rohlader J, Kjeldahl K, Curran C, et al. Reflex HPV testing of ASCUS patients: initial experience with PCR-based HPV identification and typing. Acta Cytol 2002;46:921A.
78. Depuydt C, Vereecken A, Salembier G, Vanbrabant A, Boels L, van Herck E, et al. Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women. Br J Cancer 2003;88:560-6.
79. Bolick D, Staley B, Schwarz M, Lin K. The rate of oncogenic HPV decreases with age in all Pap diagnositc groups. Acta Cytol 2002;46:921A.
80. Lu D, Ylagan L, Qin Y, Pinto K, Wang-Johanning F. Prevalence and typing of HPV DNA in different age groups and subcategories of atypicalsquamous cells (ASC). Acta Cytol 2002;46:932A.
81. Tambouret R, Crum CP, Duska L, Bell DA. Use of thin prep technology and hpv testing in cervical/vaginal smears from postmenopausal women [abstract]. Mod Pathol 2000;13:56A.
82. Ejersbo D, Jensen HA, Holund B. Efficacy of Ki-67 antigen staining in papnicolaou (pap) smears in post-menopausal women with atypia-an audit. Cytopathology 1999;10:369-74.
83. Bulten J, de Wilde PCM, Boonstra H, Gemmink JH, Hanselaar GJM. Proliferation in "atypical" atrophic pap smears. Gynecol Oncol 2000;79:225-9.
84. Mauck CK, Callahan MM, Baker J, Arbogast K, Veazey R, Stock R, et al. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception 1999;60:15-24.
85. Wilbur DC, Dubeshter B, Angel C, Atkinson KM. Use of thin-layer preparations for gynecologic smears with emphasis on the cytomorphology of high-grade intrapepithelial lesions and carcinomas. Diagn Cytopathol 1996;14:201-11.